TAL Life Insurance Australia — What You Need to Know
- 1 day ago
- 10 min read
Written by Christopher Hall, AdvDipFP | Authorised Representative, AFSL 526688 | June 2026
TAL is, on most measures, Australia's largest life insurer, holding 27.5% of individual advised death cover annual premium and 46.4% of group superannuation death cover annual premium as at December 2025 (Australian Prudential Regulation Authority, 2026) — a scale weighted heavily towards its very large group and superannuation book. TAL is wholly owned by Japan's Dai-ichi Life Group and traces its corporate heritage back more than 150 years (TAL, 2026).
Australia's life insurance industry is regulated by APRA under the Life Insurance Act 1995, with all major insurers required to submit quarterly financial data and maintain capital reserves against policyholder obligations. The consolidation of Australia's insurance market over recent years — where exiting insurers have transferred policyholder contracts to larger carriers — is a demonstration that this regulatory framework protects policyholders regardless of individual insurer changes.
TAL is on the Arrow Equities approved product list. Christopher Hall, AdvDipFP, Authorised Representative, AFSL 526688, reviews all ten insurers on the panel against each client's individual circumstances — age, occupation, medical background, cover levels, and financial position — before any recommendation is made.
Who is TAL?
TAL is wholly owned by Dai-ichi Life Group of Japan, which was founded in 1902 as Japan's first mutual life insurer and is today among the world's largest life insurers, with roughly 57,000 employees and assets of around AUD$400 billion (Dai-ichi Life Group, 2026). Dai-ichi took a minority stake in the business in 2008 and moved to full ownership in May 2011, at which point it was rebranded TAL — having previously operated in Australia under the TOWER name. The corporate lineage runs back to 1869 and the Government Life Insurance Office in New Zealand, and TAL today describes itself as protecting Australians for more than 150 years, covering over five million customers across its adviser, direct, and group or workplace channels (TAL, 2026).

By total life-risk market share, TAL is the largest insurer in the country, with around 33.6% of premiums in force in the year ended 30 September 2025 (Plan for Life, 2026). That headline position is heavily weighted by group cover — the default insurance held inside superannuation funds — which is a different product from the bespoke retail cover most advised clients hold. In the individual advised segment specifically, TAL held 27.5% of death cover annual premium as at December 2025 (Australian Prudential Regulation Authority, 2026).
TAL paid approximately $4.7 billion in claims to around 54,000 customers and their families in the 12 months to 31 March 2025 — roughly $90 million a week — of which 74% were living-insurance claims across income protection, critical illness, and TPD. Mental health was the leading cause of claims for the fourth consecutive year at 21%, followed by cancer at 17% and injuries at 15%, and TAL reports accepting 96% of all claims assessed in the period (TAL, 2025).
TAL's scale has been built partly through acquisitions, and two of those brought large legacy books with them. Asteron Life came across with TAL's purchase of Suncorp's Australian life business in 2018, and BT Life — formerly the life-products arm of Westpac's advice business — was acquired from Westpac in a sale completed on 1 August 2022 and formally transferred into TAL Life Limited on 1 April 2025. Both the Asteron and BT Life books are now closed to new business. Arrow Equities' insurer acquisition and regulatory news hub covers the broader context of how the Australian life insurance market has consolidated over this period.
What personal insurance products does TAL offer?
TAL offers the full suite of personal risk products:
Life insurance — lump-sum payment on death or terminal illness diagnosis
Total and permanent disability cover — lump-sum payment if a policyholder becomes unable to work permanently
Income protection — regular income replacement if unable to work due to illness or injury, with options for waiting period and benefit period structure
Trauma (critical illness) insurance — lump-sum payment on diagnosis of specified medical conditions
Cover can be structured inside or outside superannuation. In Christopher Hall's experience across 500+ policy reviews, TAL's product mechanics are largely conventional — there is no single structural quirk that stands out as either a distinctive advantage or a feature to watch. For TAL, the more useful part of the story for a prospective client is its pricing behaviour and the scale and heritage of the company, rather than a clever product feature.
Christopher Hall's experience with TAL clients
Across Christopher Hall's 500+ life insurance policy reviews, TAL products appear regularly as a candidate for consideration depending on the client's circumstances.
The pattern Christopher Hall returns to most often with TAL is pricing consistency. In his experience, TAL's retail premium movements have been among the more stable and restrained he has observed across recent repricing cycles — its on-sale pricing has tended to move later and more gently than the wider market, rather than in sharp steps. On total and permanent disability cover specifically — an area under industry-wide pressure from rising mental-health claims — Christopher Hall has observed TAL's recent increases sitting towards the lower end of that pressure in many of the cases he has reviewed, which works in a policyholder's favour.
One genuinely unusual illustration of that restraint: Christopher Hall has reviewed two clients in their early thirties whose TAL income protection premiums actually decreased as they aged over the first couple of policy years. He stresses this is abnormal — the only two such cases he has seen across any insurer, and an outlier that should not be read as standard, expected, or repeatable. The broader pattern he sees with on-sale TAL policies is standard, expected stepped-premium increases — the usual loyalty effect over time — but rarely the abnormally large jumps seen elsewhere.
Inherited legacy books are an industry-wide phenomenon, and Arrow Equities covers a related example in its AIA and CommInsure policy history article. In Christopher Hall's experience, TAL's book has not shown the same legacy income-protection drag to the same degree, and its Life and TPD pricing has remained competitive across his reviews.
Recent changes at TAL
There was a phase over the last 12 to 18 months in which TAL looked consistently a little more expensive than some alternatives — though, in Christopher Hall's experience, never abnormally so. He reads that as TAL repricing in line with the wider market. The notable point is the degree: even when TAL moved first in that direction, its adjustments were comparatively modest rather than dramatic, which is consistent with the broader stability pattern across his reviews.
For existing policyholders, the more important distinction is between on-sale and off-sale cover. On-sale TAL contracts attract the standard loyalty effect over time, but have tended to be more stable than most. The closed Asteron and BT Life books are a different story. Off-sale products across the industry tend to see steep, compounding annual premium increases — in the case of BT Life, some policyholders saw increases of up to around 70% in a single year around the period before and during the transfer, consistent with how stepped and level insurance premiums compare once a book is closed to new business. Christopher Hall notes this is how the industry typically prices closed books rather than a TAL-specific failing; once TAL assumed administration of these policies, policyholders gained access to a functioning servicing and back-office mechanism that had previously been difficult to deal with. These closed-book policies are the contracts most worth reviewing, because the loyalty tax — the gap between what long-standing policyholders pay and current new-business rates — compounds most severely once a product is no longer sold.
Is TAL the right insurer for a client's situation?
Whether TAL is appropriate for any individual depends on a combination of factors: age, occupation, medical history, the type and level of cover being sought, how premiums will be structured (personally funded or through superannuation), whether the cover is a current on-sale TAL policy or an inherited Asteron or BT Life contract, and what alternatives are available at the time of review.
Life insurance products sold through online comparison sites, TV advertising, or weekly premium structures are often white-labelled versions of products offered by the same major insurers. In Christopher Hall's experience across 500+ policy reviews, the product terms, definitions, and flexibility available through a licensed adviser who holds the insurer's products on an approved product list can differ significantly from those accessible through a direct online quote — sometimes from the same insurer.
Policyholders weighing up TAL, or holding an existing TAL, Asteron, or BT Life policy, may wish to compare it against the broader market with a life and TPD insurance specialist before deciding. A comprehensive life insurance review across the panel is the starting point.
Which other insurers does Arrow Equities compare TAL against?
When an existing TAL policy is being reviewed, or when TAL comes up in a new client comparison, Arrow Equities typically compares it against the other insurers on the approved product list:
Arrow Equities holds all ten on its approved product list. No insurer is recommended as a general rule — suitability is determined by the individual's circumstances at the time of review.
Frequently Asked Questions
Is TAL life insurance any good?
TAL is Australia's largest life insurer by total life-risk market share and is regulated by APRA under the Life Insurance Act 1995, submitting quarterly financial data and maintaining capital reserves against policyholder obligations as all Australian life insurers must. It offers the full suite of personal risk cover — life, total and permanent disability, income protection, and trauma. Whether TAL is the right insurer for a specific individual is determined by how it compares against the full panel for that person's circumstances — premium, product terms, definitions, and cover structure.
Is TAL the largest life insurer in Australia?
By total life-risk market share, TAL is the largest insurer in Australia, with around 33.6% of premiums in force in the year ended 30 September 2025 (Plan for Life, 2026). That figure is weighted heavily by group cover held inside superannuation funds. In the individual advised market that most advised retail clients buy in, TAL held 27.5% of death cover annual premium as at December 2025 (Australian Prudential Regulation Authority, 2026) — still the largest single share, but a more modest one than the headline total-market figure.
What happened to Asteron and BT Life policyholders when TAL took over?
Asteron Life came across with TAL's acquisition of Suncorp's Australian life business in 2018, and BT Life — formerly Westpac's life-products arm — was acquired from Westpac in a sale completed on 1 August 2022, with the business formally transferred into TAL Life Limited on 1 April 2025. Both books are now closed to new business. Once TAL assumed administration of these policies, policyholders gained access to a functioning servicing and back-office mechanism. Because closed, off-sale products across the industry tend to see steep compounding premium increases over time, these are the contracts most worth having reviewed.
Does TAL offer income protection insurance?
Yes. TAL offers income protection insurance as part of its full personal risk suite, alongside life, TPD, and trauma cover. Income protection can be structured with different waiting period and benefit period options, and cover can be held inside or outside superannuation. Eligibility, product terms, and pricing all vary by individual circumstances and occupation.
What should I check if I already have a TAL, Asteron, or BT Life policy?
Policyholders with an on-sale TAL policy may wish to have their current premium compared against current new-business rates across the panel, particularly if they have held the policy for several years or received a premium increase notice. Holders of closed Asteron or BT Life policies have the strongest reason to review, because off-sale books tend to attract the steepest compounding annual increases. A professional review can compare the existing policy against current market alternatives and confirm whether the cover still matches the policyholder's circumstances.
How does Arrow Equities compare TAL to other insurers?
Arrow Equities holds all ten panel insurers on its approved product list and compares them against each client's individual circumstances — age, occupation, health history, cover requirements, and premium structure preferences. For any client being assessed with a TAL, Asteron, or BT Life policy in scope, the comparison includes premium at the relevant age and occupation, product terms, definition quality, and fit with the client's payment structure. Arrow Equities operates on a panel basis — no single insurer is recommended as a general rule, and suitability is always assessed at the individual level.
For eligible clients, an Arrow Equities insurance review is complimentary.
Whether the review covers an existing TAL policy, an inherited Asteron or BT Life contract, or a straightforward market comparison with TAL as one of ten panel insurers — the review assesses how TAL compares against the full panel for the individual's specific circumstances, age, occupation, and cover requirements, and identifies any loyalty tax gap on long-standing or closed-book cover.
About the AuthorChristopher Hall, AdvDipFP, is the principal financial adviser at Arrow Equities and an Authorised Representative under AFSL 526688. He has completed more than 500 life insurance policy reviews for Australian families, with a specialisation in life risk insurance.
Bibliography
# | Source | Type | Date |
1 | Australian Prudential Regulation Authority 2026, Life insurance claims and disputes statistics — December 2025, APRA, Sydney, viewed June 2026, <https://www.apra.gov.au/life-insurance-claims-and-disputes-statistics> | Tier 1 — regulatory | December 2025 |
2 | Plan for Life 2026, Life risk market share and premiums in force — year ended 30 September 2025, PFL Research (via Insurance Watch), viewed June 2026, <https://www.insurancewatch.com.au/life-insurance-companies.html> | Tier 2 — independent research | February 2026 |
3 | TAL 2025, TAL supported more Australians last financial year, media release, 28 May 2025, TAL Dai-ichi Life Australia, viewed June 2026, <https://www.tal.com.au/about-us/media-centre> | Company disclosure | May 2025 |
4 | TAL 2026, Our life story, TAL Dai-ichi Life Australia, viewed June 2026, <https://www.tal.com.au/about-us/who-we-are/our-life-story> | Company disclosure | 2026 |
5 | Dai-ichi Life Group 2026, Company profile, Dai-ichi Life Holdings, viewed June 2026, <https://www.dai-ichi-life-hd.com/en/> | Company disclosure | 2026 |
Educational Disclaimer: This content is for educational purposes only and does not constitute financial advice. Past performance is no guarantee of future results.
The information, opinions and other materials appearing on the Web Site are of a general nature only and shall not be construed as advice. Arrow Equities, AFSL 526688, ABN 87 645 284 680. This general information is educational only and not financial advice, recommendation, forecast or solicitation. Rose Bay Equities accepts no responsibility for the accuracy or completeness of the information, opinions or other materials provided on or accessible through the Web Site. The Web Site has not been prepared with reference to your individual financial or personal circumstances. You should not rely on any advice in this Web Site without first seeking appropriate professional, financial and legal advice. Further, where Rose Bay Equities makes third party material available or accessible through the Web Site you acknowledge that Rose Bay Equities is a distributor and not a publisher of that content and that its editorial control is limited to the selection of those materials to make available. We accept no liability for any loss or damages arising from use.





















Comments